Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Tatnic who wrote (6293)	3/31/1999 10:54:00 PM
From: Cacaito	Read Replies (1) \| Respond to of 7041

cbs.marketwatch.com Kurt Von Ester has some comments about Zona. He was very bullish when stock near the $40s. He later claimed to be a hold $20s. Now, He seems somewhat restrained in his comments, less bullish, but somehow optimistic (trying the last trick to catch new holders?). I am bias against his comments. I am bias against Zonagen's product Vasomax/Phantolamine, poor efficacy if any.